• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    GT Biopharma To Participate In The 38th Annual Roth Conference

    GLOBENEWSWIRE

    GT Biopharma Reports Full Year 2025 Financial Results

    GLOBENEWSWIRE

    GT Biopharma to Present at 9th Annual Toronto Growth Conference

    GLOBENEWSWIRE

    GT Bio Gets FDA Nod For GTB-5550 Trike For B7-H3 Solid Tumors

    GLOBENEWSWIRE

    Functional Force Platforms to Disrupt Tumors by 2026

    PR NEWSWIRE

    GT Bio Submits IND For B7-H3-Targeted Trike In Solid Tumor Cancer

    GLOBENEWSWIRE

    GT Biopharma`s Phase 1 Advance Signals Near-Term Catalyst

    PHARMIWEB

    GT Bio Reports Q3 2025 Financials & Corporate Update

    GLOBENEWSWIRE

    GT Bio Updates Enrollment In GTB-3650 Phase 1 Trial For R/R CD33

    GLOBENEWSWIRE

    Next-Gen Targeted Therapies Transform Oncology Precision Care

    PR NEWSWIRE BIO

    GT Biopharma Updates Enrollment in Ph 1 GTB-3650 r/r CD33 Trial

    GLOBENEWSWIRE

    Novel Cancer Platforms Unite As Data Redefines Treatment Paths

    PR NEWSWIRE

    GT Bio To Participate Centurion One Capital Annual Summit

    GLOBENEWSWIRE

    Gt Biopharma to Join H.C. Wainwright Global Investment Confernece

    GLOBENEWSWIRE

    GT Biopharma Reports Second Quarter 2025 Financial Results

    GLOBENEWSWIRE

    GT Biopharma Advances GTB-3650 Ph 1 Trial to Cohort 3

    GLOBENEWSWIRE

    GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2

    GLOBENEWSWIRE

    GT Biopharma Appoints New Member to its Board of Directors

    GLOBENEWSWIRE

    GT Biopharma To Join 10th Innate Killer Summit Anniversary

    GLOBENEWSWIRE

    GT Biopharma Doses First Patient In Phase 1 GTB-3650 Trial

    GLOBENEWSWIRE

    GT Biopharma to Host Virtual Event on NK Cell Engager Oct 10

    GLOBENEWSWIRE

    GT Biopharma Reports Q2 2024 Financial Results And Corporate Update

    GLOBENEWSWIRE

    GT Announces FDA Clearance of Investigational IND Application for GTB-3650

    GLOBENEWSWIRE

    GT Bio Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia

    GLOBENEWSWIRE

    GT Biopharma Presented Positive Preclinical Data for GTB-5550

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.